Telehealth in the Rehabilitation of Urinary Incontinence in Older Women
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06200922 |
Recruitment Status :
Active, not recruiting
First Posted : January 11, 2024
Last Update Posted : January 11, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Urinary Incontinence in Old Age | Other: Pelvic physiotherapy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 69 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Participants will be divided into three groups: Synchronous Group: will receive guidance and perform a real-time guided pelvic physiotherapy protocol through online physiotherapy by the physiotherapist, Asynchronous Group: will receive guidance and perform a pelvic physiotherapy protocol after the evaluation, without the real-time monitoring by the physical therapist and face-to-face group: will receive guidelines and will perform a pelvic physiotherapy protocol oriented in person by the physical therapist. All groups will receive the same treatment for 12 weeks, which will include floor muscle training pelvic floor, urge suppression techniques, bladder training and behavioral therapy. |
Masking: | Single (Outcomes Assessor) |
Masking Description: | The evaluations will be performed by a different researcher. |
Primary Purpose: | Treatment |
Official Title: | Telehealth in the Rehabilitation of Urinary Incontinence in Older Women: Randomized Controlled Trial |
Actual Study Start Date : | April 20, 2022 |
Actual Primary Completion Date : | December 20, 2023 |
Estimated Study Completion Date : | March 20, 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: Synchronous Group
Will receive guidance and perform a real-time guided pelvic physiotherapy protocol through online physiotherapy by the physiotherapist.
|
Other: Pelvic physiotherapy
All groups will receive the same treatment for 12 weeks, which will include floor muscle training pelvic floor, urge suppression techniques, bladder training and behavioral therapy. |
Experimental: Asynchronous Group
Will receive guidance and perform a pelvic physiotherapy protocol after the evaluation, without the real-time monitoring by the physical therapist
|
Other: Pelvic physiotherapy
All groups will receive the same treatment for 12 weeks, which will include floor muscle training pelvic floor, urge suppression techniques, bladder training and behavioral therapy. |
Active Comparator: Face-to-face group
Will receive guidelines and will perform a pelvic physiotherapy protocol oriented in person by the physical therapist.
|
Other: Pelvic physiotherapy
All groups will receive the same treatment for 12 weeks, which will include floor muscle training pelvic floor, urge suppression techniques, bladder training and behavioral therapy. |
- Presence of Urinary Incontinence. [ Time Frame: Pre-treatment, at the end of the 6th week, at the end of 12 weeks. ]Application of The International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF)
- Type of Urinary Incontinence. [ Time Frame: Pre-treatment, at the end of the 6th week, at the end of 12 weeks. ]Type of UI by self-report question: What kind of Has leakage occurred more frequently in the last 7 days?
- Frequency of Urinary Incontinence [ Time Frame: Pre-treatment, at the end of the 6th week, at the end of 12 weeks. ]Self-reported frequency of leakage
- Frequency of Urinary Incontinence. [ Time Frame: Pre-treatment, at the end of the 6th week, at the end of 12 weeks. ]Self-reported use of pads.
- Overactive bladder symptoms. [ Time Frame: Pre-treatment, at the end of the 6th week, at the end of 12 weeks. ]Application of The International Consultation on Incontinence Questionnaire Overactive Bladder (ICIQ OAB)
- Quality of Life. [ Time Frame: Pre-treatment, at the end of the 6th week, at the end of 12 weeks. ]Application of The International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ- LUTSqol).
- Adherence to the study. [ Time Frame: At the end of the 6th week and at the end of 12 weeks. ]
Self-reported adherence to the protocol:
Patients will report how many days they performed the guided exercises.
- Patient's Satisfaction. [ Time Frame: At the end of 12 weeks. ]Application of The MedRisk Instrument for Measuring Patient Satisfaction With Physical Therapy Care (MRPS).
- Patient's Satisfaction. [ Time Frame: At the end of 12 weeks. ]Application of The TELEHEALTH USABILITY QUESTIONNAIRE (TUQ)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 60 Years to 100 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 60 years old or more;
- Urinary Incontinence for at least 12 months
- Internet access.
Exclusion Criteria:
- Pelvic cancer;
- Sling surgery;
- Urinary catheter;
- Antimuscarinic medication;
- Alzheimer;
- Parkinson;
- Multiple Sclerosis;
- Uncontrolled diabetes.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06200922
Brazil | |
Federal University of Health Sciences of Porto Alegre | |
Porto Alegre, Rio Grande Do Sul, Brazil, 90050-170 |
Study Director: | Luís H. Telles da Rosa | Federal University of Health Sciences of Porto Alegre (UFCSPA) |
Publications:
Responsible Party: | Luis Henrique Telles da Rosa, Clinical Professor, Federal University of Health Science of Porto Alegre |
ClinicalTrials.gov Identifier: | NCT06200922 |
Other Study ID Numbers: |
UFCSPAUI |
First Posted: | January 11, 2024 Key Record Dates |
Last Update Posted: | January 11, 2024 |
Last Verified: | January 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Urinary Incontinence Old Age Pelvic Physiotherapy Telehealth Telerehabilitation |
Urinary Incontinence Enuresis Urination Disorders Urologic Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Urogenital Diseases |
Male Urogenital Diseases Lower Urinary Tract Symptoms Urological Manifestations Behavioral Symptoms Elimination Disorders Mental Disorders |